<DOC>
	<DOC>NCT01404962</DOC>
	<brief_summary>This is a multicenter, post marketing surveillance study which aims to evaluate the safety profile of haemophilus influenza type b vaccine when administered to Korean children according to the product insert.</brief_summary>
	<brief_title>Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Male and female children 2 months to 5 years of age scheduled to receive vaccination Contraindications to Vaxemâ„¢Hib Korean Prescribing information</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Haemophilus influenza type b</keyword>
	<keyword>children</keyword>
	<keyword>Korea</keyword>
	<keyword>vaccine</keyword>
	<keyword>Prevention of haemophilus influenza type b</keyword>
</DOC>